(SRNE) - Earnings & Price History

SRNE: - 2.625, $187.95M, -0.03 (-0.94%)

Sector: Healthcare - Industry: Biotechnology

Sorrento Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, acquisition, development, and commercialization of proprietary drug therapeutics for addressing unmet medical needs worldwide. The companys primary therapeutic focus is oncology, including the treatment of chronic cancer pain, as well as developing therapeutic products for other indications, such as immunology and infectious diseases. It is developing resiniferatoxin, a non-opiate, ultra potent, and selective agonist of the TRPV-1 receptor for intractable pain in end-stage disease. The companys preclinical human therapeutic monoclonal antibodies include human anti- PD-L1 and anti-PD-1 checkpoint inhibitors; antibody drug conjugates; and bispecific antibodies, as well as Chimeric Antigen Receptor-T Cell and Chimeric Antigen Receptor Natural Killer cells for adoptive cellular immunotherapies. Sorrento Thera

Past SRNE reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2014-11-13Sorrento Therap-0.34-0.274.234.214.274.14.331.43%▲-0.94%0.48%32.60K
2014-08-19Sorrento Therap-0.34-0.335.495.555.515.455.6-0.72%-0.36%-1.08%33.00K
2014-05-21Sorrento Therap-0.28-0.445.215.245.285.155.30.76%-1.33%-0.57%114.00K

Login | Register
Friday Nov 16, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades